Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial - sprookjes - yvandenbroek - TriplyDB

Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial

Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial

http://www.wikidata.org/entity/Q33883669

about

Future pharmacological treatments for substance use disorders Immunotherapy for drug abuse Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction Biologic Approaches to Treat Substance-Use Disorders Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial Broad neutralization coverage of HIV by multiple highly potent antibodies Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans.Probing cocaine-antibody interactions in buffer and human serum Characterization of a recombinant humanized anti-cocaine monoclonal antibody produced from multiple clones for the selection of a master cell bank candidate.Vaccines against stimulants: cocaine and MA Vaccines against drugs of abuse: where are we now?Hapten optimization for cocaine vaccine with improved cocaine recognition Anti-cocaine vaccine development.Novel pharmacotherapeutic treatments for cocaine addiction.Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine.Can you vaccinate against substance abuse?The future potential for cocaine vaccines.Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs.Active immunotherapy for the Treatment of Cocaine Dependence.Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects Accelerating cocaine metabolism as an approach to the treatment of cocaine abuse and toxicity BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization.Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month period Neuroscience of behavioral and pharmacological treatments for addictions Immunopharmacotherapeutic manifolds and modulation of cocaine overdose.The effects of a humanized recombinant anti-cocaine monoclonal antibody on the disposition of cocaethylene in mice.Impact of distinct chemical structures for the development of a methamphetamine vaccine Flagellin as carrier and adjuvant in cocaine vaccine development.Immunogenicity of individual vaccine components in a bivalent nicotine vaccine differ according to vaccine formulation and administration conditions Aripiprazole maintenance increases smoked cocaine self-administration in humans.Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines.Differentiating the rapid actions of cocaine.Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats.A conjugate vaccine attenuates morphine- and heroin-induced behavior in rats Cholera toxin B: one subunit with many pharmaceutical applications.Anti-addiction vaccines.Combined active and passive immunization against nicotine: minimizing monoclonal antibody requirements using a target antibody concentration strategy

P2860

Q22242633-76F7C662-8B86-4615-8852-FC7D0E50BD76 Q26853633-E9E30E88-C291-4277-AAA9-CA20777B7EF4 Q27014154-163F2128-8667-4D88-8A77-96FBBE04C77B Q28085073-05C6E925-E29D-4E5B-8DE9-4A2A05867B60 Q28239347-E6D428A7-36C6-46F7-8ACF-578600EBEAFB Q29615361-661A541C-A3B0-4907-9962-F4C8CE858F7F Q30427490-3F7A6A46-CD2B-493B-B660-EA1636FFB97A Q31079066-4E08B209-DC92-4397-8248-A655797CDFE6 Q33459216-0377727D-AD18-4E90-A702-4DD321077F79 Q33582086-E380B603-960A-4EC9-9B17-F8577A1D6BB2 Q33776777-1488CC37-33CD-4AC3-8D6F-18F6E675D64F Q34021922-9F4A740E-753B-492A-A3AE-538517CD0F1F Q34023863-20498854-CFBE-477E-BFD1-5FE5C9848E7A Q34065088-9EFB1719-5F53-4A69-A768-283F73EAD19B Q34086657-BE5031D3-1B63-4F55-BDED-89EC4D6F1463 Q34132788-F40B7237-580E-4F26-8201-0959C79AE028 Q34132804-8AD6A78F-8400-4568-AB78-79BBCB3C6118 Q34157554-49738B7A-5B33-4D22-A5DB-A1A2766C1A60 Q34204199-A096F7FF-03E5-4065-93BF-8F5B009604E3 Q34216479-136348D9-F97F-4234-898D-6634B63BAE23 Q34251420-480F4390-9104-4658-BBFB-B9615DAB2986 Q34277168-82E4B0D1-49C4-4BC1-9945-A664B2B8CC4B Q34287658-99B65D2F-ED32-47BB-8CA7-DD87A1F7CD2A Q34389675-053C0DAB-2AF8-48A6-9EB5-05A58B14C952 Q34476304-BB67A74B-0205-4496-A80B-6AAF53BC15CB Q34602548-F289DD1A-36C9-41E3-9708-B9B767310E4B Q34714494-A076A131-C5E5-4FB6-8398-177A3E506A1A Q34754121-26F7FD0E-07B6-4A6E-84B6-59429AD75071 Q34944156-E87FFE76-E2DE-46C7-9A40-5DE3D87A4607 Q34956542-75AADF77-6F9A-4FF7-A894-58DCB84B92DB Q35057556-019DB286-30CF-42E9-ADB4-C4B18155E3FB Q35061547-B9D5E48D-7BB5-42EC-AEEA-833457D31AE2 Q35098039-F3707459-1F47-437F-839A-04CAC82B4B2F Q35120379-464C69E3-6B0B-4DD6-9CE6-49E3898388DF Q35161471-FB18BE53-6E01-45BB-BE20-DFED563CB888 Q35163178-627BBAAF-30D3-4F48-8C4B-179950CCD84E Q35224297-FF4748C4-93C6-4D0D-A22D-E34242133921 Q35232735-B04A8AD7-45F4-4E61-B0C4-2EA241AF641D Q35263981-367DECC5-0380-4072-AE72-6F66A77C5FF7 Q35476326-97298243-2A21-472C-B8C8-9B7F31E955A4

P2860

Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial

http://www.wikidata.org/entity/Q33883669

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Cocaine vaccine for the treatm ...... cebo-controlled efficacy trial

@ast

Cocaine vaccine for the treatm ...... cebo-controlled efficacy trial

@en

type

label

Cocaine vaccine for the treatm ...... cebo-controlled efficacy trial

@ast

Cocaine vaccine for the treatm ...... cebo-controlled efficacy trial

@en

prefLabel

Cocaine vaccine for the treatm ...... cebo-controlled efficacy trial

@ast

Cocaine vaccine for the treatm ...... cebo-controlled efficacy trial

@en

P1433

Q33883669-FC6BD4E5-8141-4B1F-B162-D492FD8BDA64

P1476

Q33883669-9A224965-9BCE-4B22-90CD-547197B98238

P2093

Q33883669-02547614-CB03-4D0C-A6AD-212CAF7EA8C3

Q33883669-1F94FA7E-D029-453E-A2EC-0AAFD2E4B757

Q33883669-405CBAEA-E604-4B61-BF35-1F1AEB523E54

Q33883669-4FFFCB7E-5FF3-48B9-923E-EBBA6254EABA

Q33883669-8CFAF575-7D21-4C57-991A-39B65DFC2EF6

Q33883669-AC22C5A9-7109-413A-8CCF-73311C60FA57

Q33883669-B7D81D46-C55A-4675-8312-E84A0801C1A9

P2860

Q33883669-02241FA7-98BB-4D40-BC39-4AD1C5A1F942

Q33883669-027886B3-9CB5-4B30-8828-3F3CC3FB56C8

Q33883669-0346ACAF-E22D-4B68-B323-ECD80E821E66

Q33883669-05EBC8EF-F0A9-4BA0-BF40-9E0207EE0071

Q33883669-0CDB54AB-23CA-4445-A2FA-019A77E6C71D

Q33883669-1C5502F8-9ABA-441A-8358-ACA7506C825D

Q33883669-229FE95B-8936-4BB5-92D0-D6FE25EEB3DD

Q33883669-28CAF8FF-5A57-421F-BE5F-8A2AED4A258B

Q33883669-53A9C700-3AB3-4669-98B1-2957CB4A507E

Q33883669-56BBC0AA-B6DD-4EC6-9C5B-EAF744545429

P304

Q33883669-A5A884C0-A64F-4A1F-BBB6-7225527E9BC9

P31

Q33883669-744BA88F-2BAF-40F1-9DBC-6B0A8F09FD7E

P356

Q33883669-ECAF467D-93A8-48BB-9E27-83A091CC1DE1

P407

Q33883669-50A68D57-942B-4ACE-A2B2-2BD5422FE4EA

P433

Q33883669-9C907959-DA1A-4A87-86CF-ED3F915444A6

P478

Q33883669-A58BCEAF-4E9C-458B-85DC-A74364006E65

P577

Q33883669-928BB7F4-86B1-4DBC-8BBC-DD3F14011552

P5875

Q33883669-39D44D6F-21C3-4993-ADDF-934C0313561D

P698

Q33883669-A5E3CA7C-4161-484F-AF0B-D7E8899786C3

P921

Q33883669-6A873381-5BF2-4C7A-8EFD-41ACAE92D511

Q33883669-970ED6E3-021F-4798-9456-BC841F4A59F7

P932

Q33883669-FCF8DCC7-201F-49C9-B408-0F16053FEF1F

P356

ARCHGENPSYCHIATRY.2009.128

P1433

JAMA Psychiatry

P1476

Cocaine vaccine for the treatm ...... cebo-controlled efficacy trial

@en

P2093

Bridget A Martell

http://www.w3.org/2001/XMLSchema#string

Ellen Mitchell

http://www.w3.org/2001/XMLSchema#string

Frank M Orson

http://www.w3.org/2001/XMLSchema#string

James Poling

http://www.w3.org/2001/XMLSchema#string

Roger D Rossen

http://www.w3.org/2001/XMLSchema#string

Thomas R Kosten

http://www.w3.org/2001/XMLSchema#string

Tracie Gardner

http://www.w3.org/2001/XMLSchema#string

P2860

Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders

Antidepressants for cocaine dependence

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation

Vaccine pharmacotherapy for the treatment of cocaine dependence

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

Suppression of psychoactive effects of cocaine by active immunization.

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study.

Pharmacological treatment of cocaine dependence: a systematic review.

Some relationships between addiction and drug delivery to the brain.

Psychosocial functioning and cocaine use during treatment: strength of relationship depends on type of urine-testing method

P304

1116-1123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHGENPSYCHIATRY.2009.128

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26871859

http://www.w3.org/2001/XMLSchema#string

P698

19805702

http://www.w3.org/2001/XMLSchema#string

P921

P932

2878137

http://www.w3.org/2001/XMLSchema#string